Suppr超能文献

[一名患有肝细胞癌且门静脉一级分支血栓形成的患者,接受了经导管动脉栓塞治疗]

[A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].

作者信息

Yamamoto T, Nagano H, Sakon M, Miyamoto A, Kondo M, Arai I, Morimoto O, Dono K, Umeshita K, Nakamori S, Murakami T, Nakamura H, Monden M

机构信息

Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.

出版信息

Gan To Kagaku Ryoho. 2001 Oct;28(11):1718-23.

Abstract

We report a patient with hepatocellular carcinoma (HCC) with portal vein thrombosis in the 1st branch who was treated by transcatheter arterial embolization (TAE) and survived more than 3 years. A 58-year old male was diagnosed as having unresectable massive type HCC in the area of S8 with portal vein thrombosis from the P8 branch to the right portal branch. He was treated by TAE via the anterior branch of right hepatic artery. One week later, localized hepatic infarction in the anterior segment was recognized. Five months later, the portal vein thrombosis had disappeared and become necrotic. After 3 years and 4 months, he died of a relapse of a gastric varix, but with no portal thrombosis and a well controlled intra-hepatic recurrence that was treated by repeated TAE. This case suggests that TAE might be effective for cases of HCC with portal vein thrombosis in the 1st branch, if the liver function and portal flow are suitable.

摘要

我们报告了一例肝细胞癌(HCC)患者,其肝门静脉第一分支发生血栓形成,经导管动脉栓塞术(TAE)治疗后存活超过3年。一名58岁男性被诊断为S8区不可切除的巨块型HCC,伴有从P8分支至右门静脉分支的门静脉血栓形成。通过右肝动脉前支对其进行TAE治疗。一周后,发现前段局部肝梗死。五个月后,门静脉血栓消失并坏死。3年4个月后,患者死于胃静脉曲张复发,但无门静脉血栓形成,肝内复发得到良好控制,通过重复TAE进行治疗。该病例表明,如果肝功能和门静脉血流合适,TAE可能对肝门静脉第一分支血栓形成的HCC病例有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验